• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

RealTalk MS

  • Home
  • Past Episodes
  • Videos
  • About RealTalk MS
  • Press Kit
  • Contact Us

Past Podcast Episodes

Episode 347: Vitamin D and MS with Dr. Ellen Mowry


Lower levels of Vitamin D have been associated with a higher risk of developing MS and an increase in MS disease activity. And, for years, scientists have worked to better understand the relationship between Vitamin D and MS.

Joining me to talk about the role that Vitamin D plays in MS is Dr. Ellen Mowry. Dr. Mowry is a Professor of Neurology and Epidemiology, and the Co-Director of the Multiple Sclerosis Precision Medicine Center of Excellence at Johns Hopkins University. Dr. Mowry is also one of the leading experts on Vitamin D and MS in the world.

Dr. Ellen Mowry

The National MS Society's virtual MS Activist Rally is happening in just two days, on April 25th! We're sharing registration details.

We'll tell you about a scientific breakthrough that has identified a specific autoantibody signature that can accurately predict MS years before someone experiences any MS symptoms.

We're sharing details of a clinical trial that focused on the efficacy of Ocrevus in treating Black and Hispanic people living with MS. We'll also share the details of this trial's novel design that can serve as a blueprint for successfully engaging members of minority communities in future clinical research.

We'll explain one reason why we aren't hearing as much news about the benefits of using cannabis to treat MS symptoms, and why cannabis use may actually be creating a new set of problems for people living with MS.

And we're sharing study results that show that an artificial intelligence program may have a better bedside manner than your neurologist.

We have a lot to talk about! Are you ready for RealTalk MS??!


Don't miss it! The MS Activist Rally is happening on 4/25!  :22

This Week: The relationship between Vitamin D and MS  2:50

Autoantibody signature predicts MS years before symtoms develop  3:45

Clinical trial results show that Black and Hispanic people with MS respond well to Ocrevus  7:58

Is cannabis working for people with MS?  11:13

Study results show that ChatGPT answers questions about MS with more empathy than neurologists  14:28

Dr. Ellen Mowry updates us on what the latest research is revealing about Vitamin D and MS  18:31

Share this episode  32:06

Have you downloaded the free RealTalk MS app?  32:26


SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/347

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!


LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

REGISTER for the MS Activist Rally
https://events.zoom.us/ev/Ame2jWSuHmriG94cyQmlWHr45mgnzxkDv8oMZRGsrS3ZxiSj5rro~Anqb3dHg3ewiz4KNHn2Ena4bgli_WXlza_zcygZN3GinnleB6rO15OCzGQ

STUDY: An Autoantibody Signature Predictive of Multiple Sclerosis
https://www.nature.com/articles/s41591-024-02938-3

RealTalk MS Episode 346: Why Members of Minority Communities May Face a More Severe MS Disease Course with Dr. Annette Langer-Gould
https://realtalkms.com/346

STUDY: ChatGPT vs Neurologists: A Cross-Sectional Study Investigating Preference, Satisfaction Ratings, and Perceived Empathy in Responses Among People Living with Multiple Sclerosis
https://link.springer.com/article/10.1007/s00415-024-12328-x

Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review
http://www.realtalkms.com/review


Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 347
Guest: Dr. Ellen Mowry

Privacy Policy

Filed Under: Uncategorized

Episode 346: Why Members of Minority Communities May Face A More Severe MS Disease Course with Dr. Annette Langer-Gould


In past podcast episodes, we've discussed disparities in healthcare. We've looked at evidence that shows members of historically underserved communities who live with MS may experience a more severe disease course. We've looked at studies that show some members of these racial and ethnic minority groups don't respond well to disease-modifying therapies, and their MS progresses more quickly.

It's often been speculated the reason behind these disparities is based on genetics; that members of minority communities who live with MS are genetically predisposed to experiencing a more severe disease course.

Dr. Annette Langer-Gould

My guest in this episode is Dr. Annette Langer-Gould, and Dr. Langer-Gould comes armed with evidence that points to a completely different set of answers for the cause of racial and ethnic disparities in MS disease severity and progression.

We're also sharing registration details for the National MS Society's MS Activist Rally on April 25th!

We'll tell you about an inverse vaccine that prevents the mouse model of MS (and we'll explain what an inverse vaccine is!)

You'll find out where you can find the just-released video progress report from the International Progressive MS Alliance.

We'll explain just-published results from an analysis that shows why antidiabetic and weight-loss drugs like Ozempic, Jardiance, and Trulicity may be repurposed as MS therapies.

And we're sharing study results with both good news and not so great news when it comes to being diagnosed and treated for MS in a timely manner.

We have a lot to talk about! Are you ready for RealTalk MS??!


This Week: We're exploring the reason that members of underserved minority populations who are living with MS often experience a more severe disease course  :22

The MS Activist Rally is happening on 4/25!  1:28

An inverse vaccine prevents the mouse model of MS  3:49

The International Progressive MS Alliance has released their 2024 progress report  6:13

Can weight-loss drugs be repurposed as MS therapies?  7:33

A study shows that getting diagnosed and treated for MS is dependent upon your country's healthcare system  10:26

Dr. Annette Langer-Gould has a sobering answer as to why some members of minority communities who are living with MS experience a more severe disease course  14:48

Share this episode  31:31

Have you downloaded the free RealTalk MS app?  31:51


SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/346

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!


LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

REGISTER for the MS Activist Rally
https://events.zoom.us/ev/Ame2jWSuHmriG94cyQmlWHr45mgnzxkDv8oMZRGsrS3ZxiSj5rro~Anqb3dHg3ewiz4KNHn2Ena4bgli_WXlza_zcygZN3GinnleB6rO15OCzGQ

VIDEO: International Progressive MS Alliance 2024 Progress Report
https://www.youtube.com/watch?v=4ojRaLp_J1w

STUDY: Exploring the Association Between Weight Loss-Inducing Medications and Multiple Sclerosis: Insights from the FDA Adverse Event Reporting System Database
https://journals.sagepub.com/doi/10.1177/17562864241241383

STUDY: Disease-Modifying Therapy Initiation Patterns in Multiple Sclerosis in Three Large Populations
https://journals.sagepub.com/doi/10.1177/17562864241233044

Join the RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

Download the RealTalk MS App for iOS Devices
https://itunes.apple.com/us/app/realtalk-ms/id1436917200

Download the RealTalk MS App for Android Devices
https://play.google.com/store/apps/details?id=tv.wizzard.android.realtalk

Give RealTalk MS a rating and review
http://www.realtalkms.com/review


Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 346
Guest: Dr. Annette Langer-Gould

Privacy Policy

 

 

Filed Under: Uncategorized

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Interim pages omitted …
  • Page 230
  • Go to Next Page »

Primary Sidebar

ARE YOU ON OUR MAILING LIST?

Sign up to receive email updates from RealTalk MS. You’ll get a personal advance heads-up about every upcoming podcast episode.

And P.S. — We promise to keep your private information private! We won’t sell it, trade it, or share it.

DOWNLOAD THE APP!

It’s the easiest way to connect with the RealTalk MS podcast. You’ll never miss another episode.

AND…we’re sharing free bonus content available ONLY in the RealTalk MS app.

Download the FREE RealTalk MS app today. It’s your VIP pass to the RealTalk MS community.

Follow RealTalk MS!


Connect With Us

  • Email
  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

Copyright © 2025 RealTalk MS